IgA Nephropathy Prognosis: What Is the Outlook?

IgA nephropathy prognosis explained: what affects the outlook — urine protein, eGFR, blood pressure, biopsy findings — and what helps.

11/03/26  •  23 Views

Nephrology
Dr. Mohamed Ibrahim avatar
Dr. Mohamed Ibrahim
Physician-scientist · Founder, MedicalVideos.com
Dr. Ibrahim founded MedicalVideos.com in 2007 to make medical and surgical education freely accessible to students, clinicians, and patients.
Last reviewed: 11/03/26

The first question most people ask after a diagnosis of IgA nephropathy is a fair one: what happens to me now? The honest answer is that the outlook varies widely — and that much of it is influenced by things that can be measured and, to a real degree, improved. This article explains what doctors look at when they judge prognosis in IgA nephropathy, and what helps. For the full overview of the condition, start with What Is IgA Nephropathy? and our IgA nephropathy hub.

The short version

Many people with IgA nephropathy keep good kidney function for decades, especially when protein in the urine is low and blood pressure is well controlled. A minority progress towards kidney failure over years. Because change is usually slow and silent, prognosis is less about a single prediction on day one and more about the pattern that emerges: how much protein is leaking, how kidney function trends, and how both respond to treatment.

What affects the outlook

  • Protein in the urine. The single strongest everyday marker. Higher, persistent protein leakage is linked with faster loss of kidney function; getting protein down is a central goal of treatment.
  • Kidney function (eGFR) at diagnosis and over time. A preserved eGFR that stays stable is reassuring; a steadily falling trend is not. The direction matters more than any single reading.
  • Blood pressure. High blood pressure both results from kidney damage and accelerates it. Good control protects the filters.
  • The biopsy picture. The Oxford (MEST-C) score describes inflammation versus scarring. Active inflammation may respond to treatment; established scarring does not reverse — which is why earlier diagnosis generally means more options.
  • Response to treatment. Prognosis is not fixed at diagnosis. Protein levels and blood pressure often improve on kidney-protective treatment, and risk estimates improve with them.

How doctors estimate risk

Rather than guessing, kidney specialists use validated tools. The International IgA Nephropathy Prediction Tool combines age, eGFR, urine protein, blood pressure, medicines and biopsy scores to estimate the risk of kidney function declining substantially over the following years. During follow-up, the Kidney Failure Risk Equation gives a two- and five-year estimate from age, sex, eGFR and urine albumin. These produce probabilities, not certainties — two people with the same estimate can fare very differently — and the hub page explains both tools in more detail.

What about life expectancy?

People often search for a single number, but there isn't an honest one that applies to everyone with this condition. For someone whose kidney function stays preserved, life expectancy is generally not determined by the IgA nephropathy itself. The outlook becomes more serious when kidney function declines substantially — which is exactly why monitoring and early, sustained treatment matter so much. If kidney failure does eventually develop, dialysis and transplantation are established treatments, and people live for many years with both. Our condition guides cover dialysis and transplantation in plain language.

What you can do

  • Take kidney-protective medicines exactly as prescribed, even when you feel well
  • Keep blood pressure in the target range your team sets — home readings help
  • Cut down on salt, which supports both blood pressure and protein control
  • Don't smoke, and keep cholesterol and weight in a healthy range
  • Keep every monitoring appointment and test — trends are what guide decisions
  • Ask your team what your urine protein and eGFR trends look like, and what your estimated risk is

Hearing the condition explained by a transplant nephrologist can also help: watch IgA Nephropathy — Kidney Zone Podcast, Episode 57.

References & further reading

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) — IgA Nephropathy: https://www.niddk.nih.gov/health-information/kidney-disease/iga-nephropathy

National Kidney Foundation — IgA Nephropathy: https://www.kidney.org/kidney-topics/iga-nephropathy

KDIGO 2025 Clinical Practice Guideline for the Management of IgA Nephropathy (IgAN) and IgA Vasculitis (IgAV): https://kdigo.org/guidelines/iga-nephropathy/

Mayo Clinic — IgA Nephropathy (Berger's Disease): https://www.mayoclinic.org/diseases-conditions/iga-nephropathy/symptoms-causes/syc-20352268

This article is for general education only and is not medical advice. Prognosis in IgA nephropathy is individual; your kidney specialist, who knows your results, is the right person to discuss your own outlook.

Follow Medical Videos on FacebookJoin 5M followers for daily medical videos, expert explainers, and myths busted.
Follow
0 Comments
No comments found

Related Articles

The Medical Videos NewsletterOne email a week — the best new videos and guides. Free.